Deep Breath Intelligence

Curated by Signal

Developer of AI and mass spectrometry-based platform for personalized medicine

Overview

Developer of AI and mass spectrometry-based platform for personalized medicine. The company is developing a DBI-EPIbreath®, which is a test for drug monitoring in epilepsy. This platform is used for personalized medicine for epilepsy, monitoring COPD, and metabolism.

Key facts

Founded: 2018
Headquarters: Risch Rotkreuz, Switzerland
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

5 products and services: Sign up to view

Contact

Email: Sign up to view
Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

BC Platforms
Provider of a platforms for genomic data analysis and management
Life Sciences TechnologyZurich, Switzerland
SmartGene
Develops, markets, and supports application services for the management and analysis
Life Sciences TechnologyLausanne, Switzerland
SwissLeg
Developer of prosthetic legs for amputees
Life Sciences TechnologyLugano, Switzerland

About Deep Breath Intelligence

What does Deep Breath Intelligence do?

Developer of AI and mass spectrometry-based platform for personalized medicine.

Where is Deep Breath Intelligence headquartered?

Deep Breath Intelligence is headquartered in Risch Rotkreuz, Switzerland.

When was Deep Breath Intelligence founded?

Deep Breath Intelligence was founded in 2018.

Which sector is Deep Breath Intelligence in?

Deep Breath Intelligence operates in Life Sciences Technology.

Who are Deep Breath Intelligence's competitors?

Companies similar to Deep Breath Intelligence include BC Platforms, SmartGene, and SwissLeg.